OpenAlex
PricingAboutJobs
Log inGet started
Work

Repurposing anti-diabetic drugs for the treatment of Parkinson's disease: Rationale and clinical experience

HTML

Year: 2019
Type: book-chapter
Source: Progress in brain research
Parent work: Recent Advances in Parkinson's Disease
DOI: 10.1016/bs.pbr.2019.10.008
Authors: Tom Foltynie, Dilan Athauda
Institutions: UCL Queen Square Institute of Neurology, University College London
Language: English

Topic: Parkinson's Disease Mechanisms and Treatments
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: Parkinson's disease, drug repurposing, antidiabetic drugs, GLP-1 receptor agonists, exenatide, neurodegeneration, disease progression, type 2 diabetes
SDG: Good health and well-being

Open Access status: closed

Funder: National Institute for Health and Care Research
Awards: G6358652284, A randomized, double blind, parallel group, placebo controlled trial of Exenatide once weekly over 2 years as a potential disease modifying treatment for Parkinson's disease.
OpenAlex ID: W2991554614
FWCI: 18.52
Cites: 124
Cited by: 47
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security